{
    "organizations": [],
    "uuid": "dbb29ed82d4cdb11f51c50ed411deda37bb74a02",
    "author": "",
    "url": "https://www.reuters.com/article/brief-ose-immunotherapeutics-presents-po/brief-ose-immunotherapeutics-presents-positive-ose-172-human-ex-vivo-and-preclinical-study-results-idUSFWN1R10VS",
    "ord_in_thread": 0,
    "title": "BRIEF-OSE Immunotherapeutics Presents Positive OSE-172 Human Ex-Vivo And Preclinical Study Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 19, 2018 / 5:19 PM / in 27 minutes BRIEF-OSE Immunotherapeutics Presents Positive OSE-172 Human Ex-Vivo And Preclinical Study Results Reuters Staff March 19 (Reuters) - OSE IMMUNOTHERAPEUTICS SA: * TO PRESENT NEW DATA ON OSE-172 AT AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING * ‍OSE-172, SIRPA ANTAGONIST, PREVENTS METASTASIS SPREAD IN AGGRESSIVE CANCER MODELS​ * OSE-172 ‍DECREASES TUMOR GROWTH AND SUPPRESSIVE FUNCTION OF TUMOR MYELOID CELLS * ‍OSE-172 POTENTIATES DENDRITIC CELL TUMOR ANTIGEN CROSS-PRESENTATION INCREASING T-CELL SPECIFIC ACTIVATION​ * ‍DATA BEING PRESENTED ON OSE-172 INCLUDE RESULTS FROM HUMAN EX-VIVO AND PRECLINICAL STUDIES​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)",
    "published": "2018-03-19T19:19:00.000+02:00",
    "crawled": "2018-03-19T19:50:44.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "minute",
        "immunotherapeutics",
        "present",
        "positive",
        "human",
        "preclinical",
        "study",
        "result",
        "reuters",
        "staff",
        "march",
        "reuters",
        "ose",
        "immunotherapeutics",
        "sa",
        "present",
        "new",
        "data",
        "american",
        "association",
        "cancer",
        "research",
        "annual",
        "meeting",
        "sirpa",
        "antagonist",
        "prevents",
        "metastasis",
        "spread",
        "aggressive",
        "cancer",
        "tumor",
        "growth",
        "suppressive",
        "function",
        "tumor",
        "myeloid",
        "cell",
        "potentiates",
        "dendritic",
        "cell",
        "tumor",
        "antigen",
        "increasing",
        "specific",
        "presented",
        "include",
        "result",
        "human",
        "preclinical",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}